Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue

Trends Mol Med. 2021 Aug;27(8):777-791. doi: 10.1016/j.molmed.2020.11.003. Epub 2020 Dec 9.

Abstract

Cancer treatments are increasingly effective, but can result in iatrogenic premature ovarian insufficiency. Ovarian tissue cryopreservation is the only option available to preserve fertility in prepubertal girls and young women who require immediate chemotherapy. Ovarian tissue transplantation has been shown to restore hormonal cycles and fertility, but a large proportion of the follicle reserve is lost as a consequence of exposure to hypoxia. Another crucial concern is the risk of reimplanting malignant cells together with the grafted tissue. In this review, the authors advance some challenging propositions, from prevention of chemotherapy-related gonadotoxicity to ovarian tissue cryopreservation and transplantation, including the artificial ovary approach.

Keywords: chemotherapy; fertility preservation; ovarian reserve; ovarian tissue cryopreservation; transplantation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers
  • Cell Transplantation / methods
  • Cryopreservation / methods
  • Female
  • Fertility Preservation / methods*
  • Fertility Preservation / standards
  • Humans
  • Medical Oncology / methods
  • Oocytes / cytology
  • Ovarian Follicle / cytology
  • Ovary / cytology
  • Pregnancy
  • Pregnancy Outcome

Substances

  • Antineoplastic Agents
  • Biomarkers